Condition (MeSH)
Salmonella Infections
ClinicalTrials.gov lists 79 trials for Salmonella Infections or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
13 of the 79 trials are tagged with Salmonella Infections itself; the rest are tagged with a narrower condition beneath it.
When did Salmonella Infections trials start? (24)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 4 |
| 2024 | 2 |
| 2023 | 5 |
| 2022 | 7 |
| 2021 | 6 |
| 2020 | 3 |
| 2019 | 6 |
| 2018 | 4 |
| 2017 | 3 |
Showing 10 of 24 earlier years.
No forecast is made for this condition: it averages 4.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Salmonella Infections trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 12 |
| Phase 1/2 | 4 |
| Phase 2 | 15 |
| Phase 2/3 | 1 |
| Phase 3 | 9 |
| Phase 4 | 15 |
| Not applicable | 10 |
| Observational | 13 |
How many Salmonella Infections trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Completed | 59 |
| Unknown status | 10 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Salmonella Infections trials? (7)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| Novartis | 6 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 3 |
| EuBiologics Co.,Ltd | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
Showing 5 of 7 sponsors.
Which drugs are being tested for Salmonella Infections? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| TYPHIM Vi (Salmonella typhi vaccine) | 4 |
| Typhoid Vaccine | 3 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| I.V. Meropenem | 4 |
| 1% Azithromycin | 4 |
| Typhoid Vi vaccine | 4 |
| Vi-DT | 3 |
| Vi Polysaccharide (PS) vaccine | 3 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Salmonella Infections trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Pneumonia | 12 | 2 |
| Gastroenteritis | 6 | 1 |
| Upper Respiratory Tract Infection | 4 | 1 |
| Measles | 3 | 1 |
| Abortion spontaneous | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Salmonella Infections? (48)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Retrospective Description of 27 Cases of Nontyphoidal Salmonella Meningitis in Pediatrics Over 22 Years in France Pleads for a Revision of Age Limit for the Treatment of Salmonella Gastroenteritis in Children. | The Pediatric infectious disease journal | 2026 | Yes |
| Developing a clinical prediction model to modify empirical antibiotics for non-typhoidal Salmonella bloodstream infection in children under-five in the Democratic Republic of Congo. | BMC infectious diseases | 2025 | Yes |
| Incidence and antimicrobial resistance of non-typhoidal Salmonella enterica in stool samples from children under five in peri-urban Ouagadougou, Burkina Faso. | BMC microbiology | 2025 | Yes |
| Examining geospatial and temporal distribution of invasive non-typhoidal <i>Salmonella</i> disease occurrence in sub-Saharan Africa: a systematic review and modelling study. | BMJ open | 2024 | Yes |
| Salmonellosis Including Enteric Fever. | Pediatric clinics of North America | 2022 | Yes |
Showing 5 of 48 publications.
Prevalence (1)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Rare form of salmonellosis | Point prevalence | 1-9 / 100 000 | Europe | Not stated | Unspecified |
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: rare-disease identity.